Navigation Links
Haemacure financing receives shareholder consent - Series B Warrants are amended
Date:5/14/2008

HAE:TSX

MONTREAL, May 14 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) announces that it has obtained the consent required from its shareholders to commence implementing a financing strategy designed to get back into the clinic for the pivotal Phase II/Phase III clinical trials for its next generation, all-human fibrin sealant during Q1-2009. The strategy involves the amendment of the terms and conditions of 62.5 million outstanding Series B common share purchase warrants issued by Haemacure by way of private placement in January 2007.

"I am very pleased with the level of support that our shareholders have demonstrated by approving this amendment to the Series B Warrants, thus enabling Haemacure to finance operations with the least dilution possible", said Mr. Joseph Galli, Chairman & CEO of Haemacure. "Participants in our January 2007 private placement indicated their willingness to further finance the Company based on Haemacure achieving certain value creation milestones. Haemacure is on-time and on budget to meeting the three milestones necessary to getting back into the clinic for its next generation fibrin sealant by Q1-2009. These milestones are the commissioning of the manufacturing facility (IQ/OQ) by mid '08, the production of clinical material by Fall '08, and the approval of an amendment to the IND currently open with the FDA (end '08)", continued Mr. Galli. "Concurrent with our getting back into the clinic with our fibrin sealant, we are working on strategic partnership opportunities that will enable Haemacure to rapidly become a significant player on a global scale" concluded Mr. Galli.

Each of the Series B Warrants currently entitles the holder to acquire one additional common share of Haemacure at a price of $0.20 for a period of five years from the date of issuance. As a result of the amendment, if Series B Warrants are exercised during a period of ten business days commencing on
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
2. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
3. Haemacure Reports on its annual general and special meeting of shareholders
4. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
5. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
6. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
7. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
8. Haemacure Reports Third Quarter 2007 Results
9. InfoLogix Completes $25 Million Senior Debt Financing
10. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
11. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Plano, Texas (PRWEB) June 03, 2015 ... Intelligence and Analytics solutions, today announced the launch ... Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio. ... embed additional visualization capabilities and advanced functionalities into ... of the DSX suite, Visual BI is adding ...
(Date:6/3/2015)... 03, 2015 Sitting at a computer ... in the back, neck, shoulders and/or wrists. This can ... In addition, recent research links sitting for long periods ... diseases. Fortunately, three inventors from Oakville, Ontario, are offering ... desk. , They have developed a prototype for a ...
(Date:6/3/2015)... GA (PRWEB) June 03, 2015 Fourroux ... in Duluth, GA will celebrate its grand opening with ... , The first prosthetic center of its kind in ... their family unmatched care and outcomes through use of ... Watson, CPO & CEO of Fourroux Prosthetics, states, “Our ...
(Date:6/3/2015)... TX (PRWEB) June 03, 2015 ... independent freestanding emergency rooms in the United States, announced ... Potranco facility in late June. , “I am ... in Texas with a new facility in the San ... Director of First Choice Emergency Room. , First ...
(Date:6/3/2015)... 03, 2015 Foot and Ankle ... Casey Friske ( Clarksville Division ) was recently ... Symposium of Advanced Wound Care (SAWC) and the American ... Dan Davis. The Conference was held on April ... Center in San Antonio, TX. , Dr. Casey ...
Breaking Medicine News(10 mins):Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2
... , SUNDAY, April 11 (HealthDay News) -- It,s easy to help ... according to the Alliance for a Healthier Generation. , For starters, ... active. And you can share the fun and health benefits, ... children to get on their bicycles, roller skates or blades and ...
... ... YHC magazine on April 25. , ... (Vocus) April 10, 2010 -- The Khanna institute to attend the YHC Health Expo ... CA 91361, , , , ,Khanna Institute of LASIK & Refractive surgery, an eye surgery ...
... ... York, announces the ten-year anniversary of his involvement with the Smiles for Life program. This ... directly to charities. , ... Lake, New York (Vocus) April 10, 2010 -- A dentist in a small community in ...
... ... send the equivalent of 10,000 laser targeted marketing postcards to all of your patient,s ... ... Traffic releases the easiest chiropractic marketing can be done right now in the ...
... ... presented by psychologist Paul G. Swingle, illustrates the use of neurotherapy in treating patients ... ADD, ADHD, epilepsy, stroke, learning disorders, traumatic brain injury, depression, fibromyalgia, and autistic spectrum ... ...
... ARBOR, Mich. Noting that the organization,s research "has touched ... nation," the National Cancer Institute (NCI) has renewed the Southwest ... funding package over that period expected to exceed $120 million. ... briefing by Group Executive Officer Anne F. Schott, M.D., and ...
Cached Medicine News:Health News:Khanna Institute of Vision and Your Health Connection Spring Expo 2Health News:Khanna Institute of Vision and Your Health Connection Spring Expo 3Health News:Ballston Lake Cosmetic Dentist Excited about 10th Year Participating in Smiles for Life Program 2Health News:Ballston Lake Cosmetic Dentist Excited about 10th Year Participating in Smiles for Life Program 3Health News:Chiropractic Traffic CEO Matt Prados Releases the Easiest and Fastest Free Chiropractic Marketing Method Known to Man 2Health News:Psychologist and Author Paul G. Swingle Talks about his Approach to Treating Depression and Mood Disorders in Online Forum 2Health News:Psychologist and Author Paul G. Swingle Talks about his Approach to Treating Depression and Mood Disorders in Online Forum 3Health News:SWOG cancer trials network awarded over $120 million in NCI grants 2
(Date:6/3/2015)... 3, 2015 According to ... Peripheral Vascular Devices Market (Embolic Protection, Chronic Total ... Grafts, IVC Filters, Stents, Balloons and Accessories) - ... Cardiology and Peripheral Vascular Devices Market is expected ... a CAGR of 7.4% from 2014 to 2019. ...
(Date:6/3/2015)... Conn. , June 3, 2015  SurgiQuest®, ... innovative access technologies for minimally invasive surgery (MIS) ... AirSeal® System in over 250,000 procedures.  Adoption has ... procedures over last year, driven by the company,s ... as well as geographic expansion to over 45 ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
Breaking Medicine Technology:The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4Rapid Procedure Growth With SurgiQuest's AirSeal System 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3
... 15, 2010 Menicon Co., Ltd. has announced its ... for Optimed,s CAPTIV8 communication services and i-Vue content-driven digital ... obtained exclusive distribution rights for Optimed,s products in Japan ... ) "First of all, I would like ...
... PRINCETON, N.J., Nov. 15, 2010 BioWa, Inc. announced ... with Agensys, Inc., an affiliate of Tokyo based Astellas ... ® Technology platform for the purpose of identifying ... "We are extremely pleased about our Agreement with ...
Cached Medicine Technology:Menicon Expands Partnership with Optimed in North America 2BioWa Announces License of POTELLIGENT® Technology to Agensys 2
... protease secreted by the kidney, plays ... system. The renin-angiotensin system regulates blood ... retention by the kidney. Renin is ... including decreased intravascular volume and decreased ...
... polypeptide hormones which belong to the ... TGF- superfamily is a large group ... many aspects of development, reproductive function ... incude TGF-s, bone morphogenetic proteins, growth ...
... Human Insulin-like Growth Factor Binding Protein-1 ... the liver, which specifically binds and modulates ... The role of IGFBP-1 has not been ... regulation suggests that IGFBP-1 may be involved ...
... Human Insulin-like growth factor binding protein-2 ... (further IGFBPs have been proposed) which specifically ... and IGF-II. The binding affinity of IGFBP-2 ... higher than for IGF-I [1], suggesting a ...
Medicine Products: